1. Home
  2. CGEM vs MVST Comparison

CGEM vs MVST Comparison

Compare CGEM & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • MVST
  • Stock Information
  • Founded
  • CGEM 2016
  • MVST 2006
  • Country
  • CGEM United States
  • MVST United States
  • Employees
  • CGEM N/A
  • MVST N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • MVST Industrial Machinery/Components
  • Sector
  • CGEM Health Care
  • MVST Miscellaneous
  • Exchange
  • CGEM Nasdaq
  • MVST Nasdaq
  • Market Cap
  • CGEM 730.2M
  • MVST 676.9M
  • IPO Year
  • CGEM 2021
  • MVST N/A
  • Fundamental
  • Price
  • CGEM $8.46
  • MVST $1.79
  • Analyst Decision
  • CGEM Strong Buy
  • MVST Buy
  • Analyst Count
  • CGEM 7
  • MVST 3
  • Target Price
  • CGEM $32.50
  • MVST $3.33
  • AVG Volume (30 Days)
  • CGEM 420.6K
  • MVST 6.8M
  • Earning Date
  • CGEM 03-13-2025
  • MVST 03-31-2025
  • Dividend Yield
  • CGEM N/A
  • MVST N/A
  • EPS Growth
  • CGEM N/A
  • MVST N/A
  • EPS
  • CGEM N/A
  • MVST N/A
  • Revenue
  • CGEM N/A
  • MVST $370,989,000.00
  • Revenue This Year
  • CGEM N/A
  • MVST $19.19
  • Revenue Next Year
  • CGEM N/A
  • MVST $29.35
  • P/E Ratio
  • CGEM N/A
  • MVST N/A
  • Revenue Growth
  • CGEM N/A
  • MVST 39.03
  • 52 Week Low
  • CGEM $8.36
  • MVST $0.15
  • 52 Week High
  • CGEM $30.19
  • MVST $2.87
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 27.85
  • MVST 47.90
  • Support Level
  • CGEM $8.35
  • MVST $1.60
  • Resistance Level
  • CGEM $9.51
  • MVST $2.42
  • Average True Range (ATR)
  • CGEM 0.46
  • MVST 0.19
  • MACD
  • CGEM -0.08
  • MVST -0.02
  • Stochastic Oscillator
  • CGEM 11.91
  • MVST 29.89

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.

About MVST Microvast Holdings Inc.

Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extend from core battery chemistry to battery packs.

Share on Social Networks: